Thermo Fisher Scientific Inc.TMONYSE
Loading
EBITDA Over TimeStrong
Percentile Rank79
3Y CAGR-1.3%
5Y CAGR+2.6%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-1.3%/yr
vs +17.8%/yr prior
5Y CAGR
+2.6%/yr
Recent deceleration
Acceleration
-19.2pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$11.47B-2.8%
2024$11.80B+5.4%
2023$11.20B-6.3%
2022$11.94B-0.2%
2021$11.97B+18.4%
2020$10.11B+43.9%
2019$7.02B+13.4%
2018$6.20B+22.6%
2017$5.05B+18.9%
2016$4.25B-